Literature DB >> 3956418

Alveolar development in the human fetus and infant.

A A Hislop, J S Wigglesworth, R Desai.   

Abstract

The lungs from 29 infants aged from 29 weeks of gestation to 18 weeks postnatal age were studied using morphometric analysis; total DNA was estimated in 12 of these. Alveoli could first be counted and measured at 29 weeks gestation; with increasing age they became more mature in appearance as the walls elongated and thinned, and they gradually increased in diameter. Lung volume increased 4-fold between 29 weeks and term, and further doubled in the 4 months after birth. Lung volume, alveolar surface area and DNA all increased linearly with age and weight. Alveolar number showed a curvilinear increase with age and DNA, but a linear relationship to body weight. At birth the lungs had an average of 150 million alveoli, half of the expected adult number. There was a wide normal range. The surface area was between 3 and 5 m2 at birth, one twentieth of the adult value.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3956418     DOI: 10.1016/0378-3782(86)90092-7

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  47 in total

Review 1.  Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy).

Authors:  E Eber; M S Zach
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

2.  Alveolarization continues during childhood and adolescence: new evidence from helium-3 magnetic resonance.

Authors:  Manjith Narayanan; John Owers-Bradley; Caroline S Beardsmore; Marius Mada; Iain Ball; Ruslan Garipov; Kuldeep S Panesar; Claudia E Kuehni; Ben D Spycher; Sian E Williams; Michael Silverman
Journal:  Am J Respir Crit Care Med       Date:  2011-10-27       Impact factor: 21.405

3.  Lung function in children of low birth weight.

Authors:  K N Chan; C M Noble-Jamieson; A Elliman; E M Bryan; M Silverman
Journal:  Arch Dis Child       Date:  1989-09       Impact factor: 3.791

4.  Type I collagenases in bronchoalveolar lavage fluid from preterm babies at risk of developing chronic lung disease.

Authors:  D G Sweet; K J McMahon; A E Curley; C M O'Connor; H L Halliday
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

Review 5.  Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia.

Authors:  Rita M Ryan; Qadeer Ahmed; Satyan Lakshminrusimha
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

6.  Biomimetics of the pulmonary environment in vitro: A microfluidics perspective.

Authors:  Janna Tenenbaum-Katan; Arbel Artzy-Schnirman; Rami Fishler; Netanel Korin; Josué Sznitman
Journal:  Biomicrofluidics       Date:  2018-05-29       Impact factor: 2.800

7.  Comprehensive stereological assessment of the human lung using multiresolution computed tomography.

Authors:  Dragoş M Vasilescu; André B Phillion; Daisuke Kinose; Stijn E Verleden; Bart M Vanaudenaerde; Geert M Verleden; Dirk Van Raemdonck; Christopher S Stevenson; Cameron J Hague; MeiLan K Han; Joel D Cooper; Tillie-Louise Hackett; James C Hogg
Journal:  J Appl Physiol (1985)       Date:  2020-04-16

8.  Development of human fetal lung in organ culture compared with in utero ontogeny.

Authors:  D Cossar; J Bell; M Lang; R Hume
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-04       Impact factor: 2.416

9.  Growth of the lung parenchyma early in life.

Authors:  Juan E Balinotti; Christina J Tiller; Conrado J Llapur; Marcus H Jones; Risa N Kimmel; Cathy E Coates; Barry P Katz; James T Nguyen; Robert S Tepper
Journal:  Am J Respir Crit Care Med       Date:  2008-11-07       Impact factor: 21.405

10.  Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.

Authors:  Carl T D'Angio; William M Maniscalco
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.